Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Pasadena › NPI 1407828429
Hospital

Pasadena Hospital Association, LTD

Pasadena Hospital Association, LTD was paid $24.14M by Medicaid between Jan 2018 and Dec 2024, across 246 billing codes. Its largest line is 0450, Emergency room services — 27% of everything it billed.

33Billing provider infoPASADENA HOSPITAL ASSOCIATION, LTD
PASADENA, CA 91105
33aNPI1407828429assigned 02/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$24.14M
24GClaims694,739
24DCodes billed246
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#107 of 410
Median peer was paid$6.90M
This provider vs. median3.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018106,980$2.65M
201980,941$3.90M
202091,035$3.22M
2021114,118$4.19M
2022110,274$4.41M
202394,184$3.59M
2024incomplete97,207$2.19M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 27% 61,762 54,222 $6.41M
G9002 Coordinated care fee, maintenance rate 17% 13,535 13,479 $4.21M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.1% 5,143 4,984 $993K
99281 Emergency department visit for the evaluation and management, self-limited or minor 3.5% 11,145 9,837 $847K
70450 Computed tomography, head or brain; without contrast material 3.4% 7,719 7,424 $827K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 12,640 11,809 $522K
80053 Comprehensive metabolic panel 2.2% 45,251 41,093 $521K
0202U Oncology (prostate), multianalyte, gene expression profiling 2.1% 4,251 4,108 $511K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.1% 5,774 5,441 $504K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.1% 22,326 20,064 $500K
71045 Radiologic examination, chest; single view 1.6% 20,792 19,554 $383K
96375 Therapeutic injection; each additional sequential IV push 1.4% 12,142 10,941 $346K
234 more codes
99284 Emergency room visit (serious) 1.4% 3,765 $337K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.4% 48,958 $335K
72125 Computed tomography, cervical spine; without contrast material 1.4% 3,032 $335K
76700 Ultrasound, abdominal, real time with image documentation; complete 1.3% 5,645 $322K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 5,564 $285K
71275 Computed tomographic angiography, chest, with contrast material 1.1% 1,909 $276K
99199 Unlisted special service, procedure or report <1% 6,780 $220K
96361 Intravenous infusion, hydration; each additional hour <1% 8,535 $218K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 5,219 $206K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 5,358 $190K
84484 <1% 16,075 $184K
99285 Emergency room visit (most serious) <1% 1,021 $183K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,130 $174K
93970 <1% 1,481 $168K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,617 $154K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,276 $131K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,446 $123K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,569 $116K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 893 $112K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,331 $112K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,297 $111K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 590 $110K
80306 <1% 6,518 $109K
93971 <1% 1,132 $100K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,662 $91K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 4,550 $81K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,632 $78K
83605 <1% 9,220 $72K
83880 <1% 3,971 $69K
87040 <1% 6,012 $68K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,941 $68K
0300 <1% 1,239 $68K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,967 $66K
85610 <1% 15,184 $65K
J3490 Unclassified drugs <1% 14,955 $65K
83690 <1% 11,056 $64K
76830 Ultrasound, transvaginal <1% 1,230 $61K
0250 <1% 8,019 $54K
76801 <1% 887 $48K
0259 <1% 7,834 $48K
0270 <1% 7,240 $47K
Z7502 <1% 1,277 $47K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,929 $46K
84703 <1% 7,662 $46K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,674 $42K
73630 <1% 1,548 $39K
81001 <1% 14,051 $39K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 914 $39K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,082 $36K
84145 <1% 2,916 $33K
76942 <1% 801 $33K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 668 $33K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,836 $31K
0160 <1% 974 $31K
72131 <1% 191 $31K
81003 <1% 12,776 $31K
84702 <1% 3,358 $30K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 634 $30K
90715 <1% 954 $29K
80048 Basic metabolic panel (calcium, ionized) <1% 2,715 $29K
73610 <1% 1,202 $29K
85730 <1% 5,161 $27K
73030 <1% 1,208 $27K
73130 <1% 1,025 $26K
96367 <1% 862 $26K
0272 <1% 1,464 $26K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,899 $25K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,471 $25K
70486 <1% 251 $24K
84443 Thyroid stimulating hormone (TSH) <1% 2,392 $23K
86850 <1% 2,785 $22K
71250 <1% 259 $22K
94762 <1% 1,318 $22K
0949 <1% 170 $21K
Z7500 <1% 584 $20K
82948 <1% 3,227 $20K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,323 $19K
83735 <1% 3,225 $19K
74174 <1% 132 $19K
71046 Radiologic examination, chest; 2 views <1% 802 $19K
85379 <1% 2,172 $17K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,354 $17K
86140 <1% 3,284 $17K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 872 $16K
76770 <1% 237 $16K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,269 $16K
87186 <1% 2,006 $16K
G0378 Hospital observation service, per hour <1% 349 $16K
86900 <1% 3,544 $15K
80047 <1% 2,136 $15K
93975 <1% 124 $15K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,784 $14K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 228 $14K
0762 <1% 99 $13K
73564 <1% 382 $13K
36415 Collection of venous blood by venipuncture <1% 12,497 $13K
72100 <1% 428 $12K
86141 <1% 1,812 $12K
82550 <1% 2,670 $12K
81002 <1% 5,026 $11K
87581 <1% 617 $11K
81025 <1% 2,733 $11K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,850 $11K
87486 <1% 618 $11K
86901 <1% 3,484 $11K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 627 $10K
0710 <1% 348 $10K
94760 <1% 1,352 $10K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 319 $10K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 768 $10K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 767 $10K
70498 <1% 122 $10K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,084 $9K
74018 <1% 539 $9K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,225 $9K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 98 $9K
99000 <1% 3,150 $9K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,044 $9K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,175 $9K
96376 <1% 2,458 $8K
73562 <1% 353 $8K
86769 <1% 183 $8K
J2060 Injection, lorazepam, 2 mg <1% 2,012 $8K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 1,144 $7K
70496 <1% 69 $7K
73560 <1% 417 $7K
80050 General health panel <1% 594 $6K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,075 $6K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 13 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 755 $6K
84439 <1% 964 $6K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,796 $6K
70551 Magnetic resonance imaging, brain; without contrast material <1% 41 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 183 $6K
P9016 Red blood cells, leukocytes reduced, each unit <1% 75 $6K
87077 <1% 1,191 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 524 $5K
27502 <1% 20 $5K
36430 <1% 76 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 379 $5K
J1815 Injection, insulin, per 5 units <1% 190 $5K
80061 Lipid panel <1% 567 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,202 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 749 $4K
85652 <1% 1,368 $4K
99070 <1% 256 $4K
97010 <1% 183 $3K
87081 <1% 737 $3K
85014 <1% 2,035 $3K
A4649 Surgical supply; miscellaneous <1% 1,729 $3K
87088 <1% 720 $3K
82728 <1% 304 $3K
0271 <1% 572 $3K
73590 <1% 146 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 632 $3K
76870 <1% 52 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 119 $2K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 336 $2K
73502 <1% 85 $2K
0320 <1% 186 $2K
97163 <1% 52 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 392 $2K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 69 $2K
73090 <1% 68 $1K
84100 <1% 457 $1K
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 1,155 $1K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 13 $1K
73110 <1% 70 $1K
E0112 Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips <1% 123 $1K
S0164 Injection, pantoprazole sodium, 40 mg <1% 183 $1K
86308 <1% 328 $1K
83615 <1% 224 $1K
80320 <1% 756 $989.95
J3370 Injection, vancomycin hcl, 500 mg <1% 118 $977.62
99001 <1% 95 $954.88
J3475 Injection, magnesium sulfate, per 500 mg <1% 220 $953.54
0510 <1% 346 $865.83
71010 <1% 75 $863.62
87205 <1% 370 $849.62
J2704 Injection, propofol, 10 mg <1% 108 $804.29
J3486 Injection, ziprasidone mesylate, 10 mg <1% 14 $776.80
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 12 $761.80
J3010 Injection, fentanyl citrate, 0.1 mg <1% 299 $710.73
74021 <1% 17 $703.90
80076 <1% 124 $648.46
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 378 $541.82
72040 <1% 41 $522.98
J2800 Injection, methocarbamol, up to 10 ml <1% 97 $494.09
0636 <1% 64 $445.90
86923 <1% 13 $439.42
82803 <1% 48 $429.30
85027 <1% 121 $426.87
85007 <1% 190 $408.74
73100 <1% 29 $381.04
87420 <1% 143 $370.18
82330 <1% 45 $359.21
0258 <1% 79 $327.96
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 176 $321.58
73140 <1% 25 $307.93
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 12 $258.91
J1644 Injection, heparin sodium, per 1000 units <1% 120 $244.22
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 298 $240.09
J1630 Injection, haloperidol, up to 5 mg <1% 77 $234.49
84436 <1% 114 $222.23
Z7610 <1% 32 $214.27
J3360 Injection, diazepam, up to 5 mg <1% 48 $198.14
76937 <1% 14 $163.27
94644 <1% 20 $157.89
84295 <1% 44 $153.82
J0456 Injection, azithromycin, 500 mg <1% 31 $153.59
84132 <1% 44 $152.40
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 251 $140.94
S0028 Injection, famotidine, 20 mg <1% 74 $127.22
82947 <1% 44 $125.63
J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg <1% 81 $124.43
87210 <1% 28 $105.09
82010 <1% 39 $99.31
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 174 $89.22
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 19 $72.41
82150 <1% 28 $67.71
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 95 $62.61
J2470 Injection, pantoprazole sodium, 40 mg <1% 13 $55.87
J7510 Prednisolone oral, per 5 mg <1% 42 $47.88
82570 <1% 31 $47.42
87147 <1% 13 $34.56
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 39 $28.03
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 26 $27.06
82607 <1% 12 $26.84
J1171 Injection, hydromorphone, 0.1 mg <1% 25 $14.10
96379 0% 19 $0.00
0301 0% 19 $0.00
80349 0% 28 $0.00
90686 0% 13 $0.00
G0008 Administration of influenza virus vaccine 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMORGAN, LORI (PRESIDENT AND CEO)
Same official

Other billing entities under MORGAN, LORI

Full network →
ProviderLocationPaid
Tioga CountyOwego, NY$6.05M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.